SCHEMBL30982885

SCHEMBL30982885

CCCCCCCCCCCCCCCCn1ccc(=O)c(OCc2ccc(OC)cc2)c1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CNR2 P34972 2/20 0.38
▸ CNR1 P21554 2/20 0.38
▸ ACHE P22303 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MMP2 P08253 2/20 0.37
▸ MMP9 P14780 2/20 0.37
▸ MMP8 P22894 2/20 0.37
▸ MMP13 P45452 2/20 0.37
▸ PLA2G4A P47712 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982409 1.00 NPC1 (0.39) NPC1RAB9ATDP1CNR2CNR1
SCHEMBL30983036 1.00 NPC1 (0.39) NPC1RAB9ATDP1CNR2CNR1
SCHEMBL30982757 0.89 CNR2 (0.41) NPC1CNR2ACHEHTTSMN1; SMN2
SCHEMBL30982975 0.89 CNR2 (0.41) NPC1CNR2ACHEHTTSMN1; SMN2
SCHEMBL30982516 0.89 CNR2 (0.41) NPC1CNR2ACHEHTTSMN1; SMN2
SCHEMBL30982466 0.88 HTT (0.51) NPC1HTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL30982820 0.88 HTT (0.51) NPC1HTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL30982659 0.88 HTT (0.51) NPC1HTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL30982389 0.85 HTT (0.51) NPC1CNR2CNR1ACHEHTT
SCHEMBL30982613 0.85 HTT (0.51) NPC1CNR2CNR1ACHEHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 INFINEUM INTERNATIONAL LIMITED (US) 2025-12-23 — — US disclosed
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294842-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294841-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240287405-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 INFINEUM INTERNATIONAL LIMITED (US) 2024-08-29 — — US disclosed
EP-4417673-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417674-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417672-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417675-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
CN-118516151-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516152-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516153-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516154-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 SIGMAR1, OXGR1, OPRM1 NPC1 4695/4885RAB9A 3759/4885TDP1 652/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 NPC1 2137/4885RAB9A 4430/4885TDP1 2067/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 NPC1 1838/4885RAB9A 4039/4885TDP1 1619/4885
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 SIGMAR1, OXGR1, OPRM1 NPC1 4695/4885RAB9A 3759/4885TDP1 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback